feed,title,long_url,short_url
Benzinga,SpringWorks Therapeutics Stock Is Trading Higher After Nirogacestat Combo Study Starts Dosing In Multiple Myeloma Patients,https://benzinga.com/general/biotech/21/04/20445636/springworks-therapeutics-stock-is-trading-higher-after-nirogacestat-combo-study-starts-dosing-in-,https://j.mp/2OiwYPu
